Comparison Overview
Lonza BioResearch Solutions

Lonza BioResearch Solutions
8830 Biggs Ford Rd, Walkersville, 21793, US
Last Update: 05/12/2025
Lonza Bioscience Solutions serves research customers globally in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions.

Amgen
One Amgen Center Drive, Thousand Oaks, CA, US, 91320
Last Update: 14/06/2026
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human gene...
Compliance Ranges Comparison

Lonza BioResearch Solutions







Amgen






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Lonza BioResearch Solutions in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Amgen in 2026.
Incident History - Lonza BioResearch Solutions (X = Date, Y = Severity)
Lonza BioResearch Solutions cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Amgen (X = Date, Y = Severity)
Amgen cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Lonza BioResearch Solutions

Amgen
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.